Mutualists to Opportunists: Ecological Duality and Lifestyle Switching in Actinomycetes

Actinomycetes belong to the most metabolically versatile microorganisms and are present in a range of ecological niches as plant growth promoting symbionts, marine and insect associated mutualists, decomposers and opportunistic pathogens. Recent advances in genomics, metagenomics and natural product discovery have revealed that these distinct lifestyles are not discrete biological states, but alternative expressions of a shared genetic and regulatory framework. The biosynthetic gene clusters (BGCs) such as polyketide synthase (PKS), non-ribosomal peptide synthetase (NRPS), hybrid PKS-NRPS and siderophore pathways encode metabolites mediating nutrient acquisition, microbial competition, host colonization, defence and virulence and are at the core of this ecological flexibility. In this review we integrate current knowledge on the mechanisms behind actinomycete ecological duality in terrestrial, marine, plant, insect, animal and human-associated environments. We discuss the way secondary metabolism, quorum-sensing systems, biofilm formation, stress-response pathways and host–microbe interactions are involved in beneficial symbioses, while the same molecular toolkit can be adapted for opportunistic pathogenicity under conditions of host stress, immune suppression or microbiome dysbiosis. Particular attention is directed to model systems like plant-associated Streptomyces , marine and insect symbioses, pathogenic Nocardia , Rhodococcus equi and phytopathogenic Streptomyces species. We also review the roles of horizontal gene transfer, pathogenicity islands, virulence plasmids, and genomic plasticity in promoting ecological transitions and niche adaptation. Finally, we propose an integrative framework at which environmental signals, host physiology, microbial community structure and regulatory networks combine in order to determine whether actinomycetes act as beneficial symbionts or opportunistic pathogens. Understanding the mechanisms controlling these lifestyle transitions will be critical to exploit actinomycetes for sustainable agriculture, biotechnology and drug discovery and to minimize the risks of emerging infectious diseases.